BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20501286)

  • 1. D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release.
    Fuxe K; Agnati LF; Andersson K; Cintra A; Härfstrand A; Zoli M; Eneroth P; Goldstein M
    Neurochem Int; 1988; 13(2):165-78. PubMed ID: 20501286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements.
    Meister B; Hökfelt T; Tsuruo Y; Hemmings H; Ouimet C; Greengard P; Goldstein M
    Neuroscience; 1988 Nov; 27(2):607-22. PubMed ID: 2905789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic amp-regulated phosphoprotein-32 immunoreactive neuronal structures and d1 receptor antagonist binding sites in various brain regions of the male rat-mismatches indicate a role of d1 receptors in volume transmission.
    Fuxe K; Cintra A; Agnati LF; Härfstrand A; Goldstein M
    Neurochem Int; 1988; 13(2):179-97. PubMed ID: 20501287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1 and D2 receptor immunoreactivities in the arcuate-median eminence complex and their link to the tubero-infundibular dopamine neurons.
    Romero-Fernandez W; Borroto-Escuela DO; Vargas-Barroso V; Narváez M; Di Palma M; Agnati LF; Larriva Sahd J; Fuxe K
    Eur J Histochem; 2014 Jul; 58(3):2400. PubMed ID: 25308843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function.
    Härfstrand A; Fuxe K; Agnati LF; Eneroth P; Zini I; Zoli M; Andersson K; von Euler G; Terenius L; Mutt V; Goldstein M
    Neurochem Int; 1986; 8(3):355-76. PubMed ID: 20493065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometrical analysis of the distribution of luteinizing hormone-releasing hormone and tyrosine hydroxylase-immunoreactive nerve terminals within the lateral palisade zone of the median eminence of the male rat.
    Calza L; Agnati LF; Fuxe K; Giardino L; Goldstein M
    Neurosci Lett; 1983 Dec; 43(2-3):179-83. PubMed ID: 6143286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic regulation of luteinizing hormone-releasing hormone release at the median eminence level: immunocytochemical and physiological evidence in hens.
    Contijoch AM; Gonzalez C; Singh HN; Malamed S; Troncoso S; Advis JP
    Neuroendocrinology; 1992 Mar; 55(3):290-300. PubMed ID: 1354335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between neuropeptide Y and luteinizing-hormone-releasing hormone immunoreactivities in the hypothalamus and preoptic region.
    McDonald J; Calka J
    Acta Anat (Basel); 1994; 151(3):171-9. PubMed ID: 14758849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback.
    Advis JP; McCann SM; Negro-Vilar A
    Endocrinology; 1980 Oct; 107(4):892-901. PubMed ID: 6997020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.
    Meister B; Ceccatelli S; Hökfelt T; Andén NE; Andén M; Theodorsson E
    Exp Brain Res; 1989; 76(2):343-68. PubMed ID: 2569986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-endorphin regulation of luteinizing hormone-releasing hormone release at the median eminence in ewes: immunocytochemical and physiological evidence.
    Conover CD; Kuljis RO; Rabii J; Advis JP
    Neuroendocrinology; 1993 Jun; 57(6):1182-95. PubMed ID: 8232772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluorimetric quantitation of catecholamine fluorescence in rat median eminence. I. Aspects on the distribution of dopamine and noradrenaline nerve terminals.
    Löfström A; Jonsson G; Fuxe K
    J Histochem Cytochem; 1976 Feb; 24(2):415-29. PubMed ID: 1254939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain.
    Ouimet CC; LaMantia AS; Goldman-Rakic P; Rakic P; Greengard P
    J Comp Neurol; 1992 Sep; 323(2):209-18. PubMed ID: 1328330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation of the short-loop negative feedback of luteinizing hormone (LH) on LH-releasing hormone release by melatonin-induced inhibition of LH release from the pars tuberalis.
    Nakazawa K; Marubayashi U; McCann SM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7576-9. PubMed ID: 1881898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat.
    Andersson K; Fuxe K; Eneroth P; Agnati LF
    Acta Physiol Scand; 1982 Sep; 116(1):41-50. PubMed ID: 6818838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial preoptic microimplants of the antiestrogen, keoxifene, affect luteinizing hormone-releasing hormone mRNA levels, median eminence luteinizing hormone-releasing hormone concentrations and luteinizing hormone release in ovariectomized, estrogen-treated rats.
    Petersen SL; Cheuk C; Hartman RD; Barraclough CA
    J Neuroendocrinol; 1989 Aug; 1(4):279-83. PubMed ID: 19210441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
    Rivest S; Plotsky PM; Rivier C
    Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural localization of luteinizing hormone-releasing hormone in the median eminence of the rat.
    Goldsmith PC; Ganong WF
    Brain Res; 1975 Oct; 97(2):181-93. PubMed ID: 1100199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of luteinizing hormone-releasing hormone in the preoptic area and hypothalamus of the rat using radioimmunoassay.
    Wheaton JE; Krulich L; McCann SM
    Endocrinology; 1975 Jul; 97(1):30-8. PubMed ID: 1095362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.